| # | Drug | Count |
|---|---|---|
| 0 | BUDESONIDE | 25 |
| 1 | ETOPOSIDE | 24 |
| 2 | IFOSFAMIDE | 20 |
| 3 | IFOSFAMIDE FOR INJECTION | 20 |
| 4 | HISTRELIN ACETATE | 19 |
| 5 | METHOTREXATE SODIUM | 18 |
| 6 | METHOTREXATE | 16 |
| 7 | SOMATROPIN | 16 |
| 8 | CARBOPLATIN | 15 |
| 9 | METHYLPHENIDATE HYDROCHLORIDE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HISTRELIN ACETATE | 19 | 0.0217 |
| 1 | DACTINOMYCIN | 14 | 0.0063 |
| 2 | IMIPRAMINE PAMOATE | 1 | 0.0061 |
| 3 | SETMELANOTIDE | 1 | 0.0035 |
| 4 | DEFLAZACORT | 6 | 0.0023 |
| 5 | TESTOSTERONE ENANTHATE | 3 | 0.0018 |
| 6 | NITISINONE | 1 | 0.0010 |
| 7 | BETAINE | 1 | 0.0010 |
| 8 | IFOSFAMIDE FOR INJECTION | 20 | 0.0009 |
| 9 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | 2 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 52 |
| 1 | Atypical Antipsychotic [EPC] | 33 |
| 2 | Alkylating Drug [EPC] | 25 |
| 3 | Topoisomerase Inhibitor [EPC] | 24 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 16 |
| 6 | Platinum-based Drug [EPC] | 15 |
| 7 | Actinomycin [EPC] | 14 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 11 |
| 9 | Purine Antimetabolite [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 14 | 0.0063 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 2 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 3 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 4 | Methylating Agent [EPC] | 1 | 0.0010 |
| 5 | Recombinant Human Growth Hormone [EPC] | 10 | 0.0005 |
| 6 | Topoisomerase Inhibitor [EPC] | 24 | 0.0003 |
| 7 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |